pragmatic asthma studies

Slides:



Advertisements
Similar presentations
Cardiovascular outcome in patients with dysglycemia with daily supplementation of n-3 fatty acids 1 ORIGIN trial (Outcome Reduction with an Initial Glargine.
Advertisements

Update: AHEAD Asthma Protocol QI Project Presented by: Katie Loveland, MPH, MSW.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2011.
® Introduction The Skinny on Obesity in Texas: BMI in Texas Family Medicine Clinics Kristin M. Yeung, Ramin Poursani, MD, Sandra K. Burge, PhD The University.
Homelessness among Veterans with Serious Mental Illness Public Health Impact and Outreach Amy M. Kilbourne, PhD, MPH VA Ann Arbor Center for Clinical Management.
® Introduction Low Back Pain Remedies and Procedures: Helpful or Harmful? Lauren Lyons, Terrell Benold, MD, Sandra Burge, PhD The University of Texas Health.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
Indianapolis Discovery Network for Dementia Comparative Effectiveness Research Trial of Alzheimer’s Disease Drugs: COMET-AD.
CRUSADE: A National Quality Improvement Initiative CRUSADE: A National Quality Improvement Initiative Can Rapid Risk Stratification of Unstable Angina.
® Introduction Back Pain Flare Ups, Physical Function, and Opioid Use Adriana Gonzalez, Darryl White MD, Sandra Burge PhD The University of Texas Health.
® From Bad to Worse: Comorbidities and Chronic Lower Back Pain Margaret Cecere JD, Richard Young MD, Sandra Burge PhD The University of Texas Health Science.
CHI CAGO The Coordinated Healthcare Interventions for Childhood Asthma Gaps in Outcomes (CHICAGO Trial) Valerie Press, MD, MPH Assistant Professor, Section.
My Own Health Report: Case Study for Pragmatic Research Marcia Ory Texas A&M Health Science Center Presentation at: CPRRN Annual Grantee Meeting October.
Electronic Health Records and Clinical Decision Support Systems Impact on National Ambulatory Care Quality Max J. Romano, BA; Randall S. Stafford, MD,
... for our health Wisconsin Research and Education Network and the University of Wisconsin Department of Family Medicine Collaboration Among Pharmacists.
Effects of Pediatric Asthma Education on Hospitalizations and Emergency Department Visits: A Meta-Analysis June 3, 2007 Janet M. Coffman, PhD, Michael.
Asthma Disparities – A Focused Examination of Race and Ethnicity on the Health of Massachusetts Residents Jean Zotter, JD Director, Asthma Prevention and.
Neurodevelopmental Disorders Research Center Subject Registry Core A Brief Overview 6/28/2007 University of North Carolina Neurodevelopmental Disorders.
The Center for Health Systems Transformation
Barb Supanich, RSM, MD, FAAHPM Holy Cross IP Palliative Care Team November 11, 2010.
The 2015 PCORI Annual Meeting: Progress in Building a Patient-Centered Comparative Clinical Effectiveness Research Community Innovative Features of the.
Adverse Outcomes After Hospitalization and Delirium in Persons with Alzheimer Disease Charles Wang, PharmD Candidate.
Predictors of Asthma in Young Children Does Reporting Source Affect Our Conclusions? Jane E. Miller Jane E. Miller, Ph.D. Institute for Health, Health.
OFEV ® (nintedanib) TOMORROW trial results Last updated These slides are provided by Boehringer Ingelheim for medical to medical education only.
PFF Teal = MAIN COLORS PFF Green = Light Green = Red = HIGHLIGHT COLORS Light Grey = Dark Grey =
Efficacy of Combination First Line Agents for Smoking Cessation Sneha Baxi, Pharm.D. Pharmacy Practice Resident University of Illinois at Chicago.
Asthma in a Nutshell Holger Link, MD. The Complexity of Asthma Immune System Environment Injury and Repair Genes.
Impact of an Electronic Health Record on the Promotion of NIH Asthma Guidelines in the Primary Care Setting Natalie Langston-Davis, MD, MPH Children’s.
Ross T. Tsuyuki, BSc(Pharm), PharmD, MSc, FCSHP, FACC Yazid NJ Al Hamarneh, BPharm, PhD Charlotte Jones, MD, PhD, FRCP(C) Brenda Hemmelgarn, MD, PhD, FRCP(C)
Lancet Respir Med 2013; 1: 199–209 R4.신재령 / Prof. 박명재
LSU Journal Club Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD WISDOM study H. Magnussen MD, et al. Nisha Loganantharaj, PGY1 April 21,
NAAT identified chlamydial infections: Enhanced sensitivity, reduced transmissibility? Presenter: Maria Villarroel, MA Authors: Maria A. Villarroel, MA.
Daniel B. Jamieson, Elizabeth C. Matsui, Andrew Belli1, Meredith C. McCormack, Eric Peng Simon Pierre-Louis, Jean Curtin-Brosnan, Patrick N. Breysse, Gregory.
Effectiveness of Patient Navigation on Diagnostic Interval, Anxiety, and Satisfaction of Minority Women with Abnormal Mammograms: a Randomized Controlled.
Date of download: 6/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Comparison of Physician-, Biomarker-, and Symptom-Based.
The PRECIS-2 tool: Matching Intent with Methods David Hahn, MD, MS, WREN Director Department of Family Medicine & Community Health University.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Health Statistics Injury and illness episodes.
Shubhangi Arora1; Eden Haverfield2; Gabriele Richard2; Susanne B
Presented by Duyen Le and Brian Nguyen
Decline OR Unable to Contact
Background Post-transplant outcomes in adult Fontan patients remain poorly defined. Available studies limited to sub-groups within published registry data.
In My Practice: Asthma in Portugal
Decision to Change Practice Review of the Literature
Cheryl Schraeder, RN, PhD, FAAN Health Systems Research Center
Participants 18year old+
Table 1: Patient Demographics
Research Questions Does integration of behavioral health and primary care services, compared to simple co-location, improve patient-centered outcomes in.
Research where it is most needed National Respiratory Strategy
Promoting male partner and couples testing through secondary distribution of self-tests by pregnant and postpartum women: a randomized trial Kawango Agot1,
Douglas S. Bell, MD, PhD Leader, UCLA CTSI Informatics Program
Implementation Challenges of Wound Interdisciplinary Teams (WIT): A Community‐Based Pragmatic Randomised Controlled Trial.
Veterans with life-limiting illness: Baseline descriptors
Believed discrimination occurred because of their:
Evidence of a Program's Effectiveness in Improving Colorectal Cancer Screening Rates in Federally Qualified Health Centers Robert L. Stephens, PhD, MPH1;
Blood eosinophil count and exacerbation risk in patients with COPD
A DIGITAL, END-TO-END, NATIONWIDE, PRAGMATIC TRIAL OF SCREENING FOR UNDIAGNOSED ATRIAL FIBRILLATION: PRIMARY RESULTS OF THE mSToPS TRIAL Steven R. Steinhubl,
12 months before treatment 12 months after treatment
M. Bradley Drummond, MD MHS Associate Professor, Pulmonary Medicine
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Revisione dei Trial Clinici sulle Malattie Ostruttive dell’ultimo anno
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
The efficacy and safety of omalizumab in pediatric allergic asthma
Identificazione del sottogruppo di pazienti responsivi
Jason Springer MD MS Mei Liu PhD
Asthma Education for Families and HCPs
HPV Vaccination in Communities with High Rates of Cervical Cancer:
Provider Counseling for Immunizations in Primary Care Settings
Khai Hoan Tram, Jane O’Halloran, Rachel Presti, Jeffrey Atkinson
Doing research in the Pediatric ED
Presentation transcript:

pragmatic asthma studies Limitations of electronic health records in identifying study participants for pragmatic asthma studies Michelle L. Hernandez MD, Kathleen M. Mottus PhD, Michelle C Hayes BA, Jennifer Rees RN CPF CRN, Tamera Coyne-Beasley MD North Carolina Network Consortium North Carolina Translational and Clinical Sciences (NC TraCS) Institute June 24, 2019

3x more likely to be hospitalized 4.5x more likely to visit ED Blacks and Hispanics have a disproportionately higher asthma burden (2007-2009) 3x more likely to be hospitalized 4.5x more likely to visit ED Higher mortality: 3x more likely to die from asthma-related causes CDC National Surveillance of Asthma: US, 2001-2010

Reasons for this disparity? Lack of education and/or understanding that controller meds need to be used even when symptoms NOT present PeRson EmPowered Asthma RElief (PREPARE) Study Pragmatic comparative effectiveness trial in Blacks & Hispanics with poorly controlled asthma on a daily inhaled corticosteroid (ICS) therapy Bigger font Erick Forno; Published in: Juan C. Celedón; Am J Respir Crit Care Med  2012

1 study visit: video consent , baseline data, inhaler video PREPARE Study Design AA or H/L adults at risk for asthma exacerbations PARTICS + 1 study visit: video consent , baseline data, inhaler video Or 15 Monthly Surveys Standard of Care Primary Endpoint: Asthma exacerbations Treatment with systemic corticosteroid therapy Patient-Activated Reliever-Triggered Inhaled CorticoSteroid (PARTICS)

PREPARE identified participants using Electronic Health Records (EHRs) Queries of EHRs are being heavily leveraged as a potential cost-effective method for participant identification In previous studies using a minority population Blacks and Exacerbations on LABA v. Tiotropium (BELT)] (Wechsler et al, JAMA 2015) Study sites recruited ~14% of EHR-identified patients (1100/~8000) PREPARE study assumptions used the BELT EHR experience EHRs can identify patients taking the required medications Assume 80% of those identified will qualify when screened UNC Chapel Hill is one of 18 participating sites UNC’s first pragmatic asthma clinical trial

4-Part Identification Strategy Potential Patients Identified (Data Warehouse) Step 1: Carolina Data Warehouse (CDW) submission Asthma in the problem list Ages 18-74 Alive Hispanic/Latino, Black/African-American Chart Review Made Contact Screened Patients Seen for asthma diagnosis in the past year On a daily ICS or ICS/LABA therapy Does not have another chronic lung disease other than asthma Scheduled and Enrolled

4-Part Identification Strategy Potential Patients Identified (Data Warehouse) Step 2: CDW refinement From CDW identified patients: Review from clinics whose providers have agreed to have their patients contacted & Who reviewed the Asthma IQ guidelines Chart Review Made Contact 1038 patients Screened Patients Time? Processing Data Warehouse 3 hours per quarter Scheduled and Enrolled

4-Part Identification Strategy Potential Patients Identified (Data Warehouse) Step 3 Review the EHR (clinical notes, med list, & PFTs) Confirm current medication PFT values ACT scores Chart Review 1038 Patients 479 eligible after chart review 46% sensitivity Made Contact Screened Patients Time? 30 minutes/chart x 1038 charts 239 hours to identify eligible participants 288 hours to exclude ineligible participants Scheduled and Enrolled

4-Part Identification Strategy Potential Patients Identified (Data Warehouse) Step 4 Contact potential participants Review recent exacerbations & updated ACT 411 eligible after phone screen Sensitivity: 39.5% Chart Review Made Contact Time? 30 minutes/phone call x 479 205 hours to identify eligible participants 34 hours to exclude ineligible participants Screened Patients Scheduled and Enrolled Time? Study visit: 2 hours

Phone Interview for Pre-Eligible Study Participants

Most commonly identified reasons for ineligibility 10% 348 patients’ medications were not correctly captured 51.5% of ineligible participants

Conclusions Our EHR had low sensitivity for identifying participants for a pragmatic asthma clinical trial UNC PREPARE: 46% qualified after chart review; 39.5% after phone screen Significant research coordinator time spent reviewing EHRs from ineligible participants Based on data input to the data warehouse BELT study: 80% qualified after screen EHR use intended to promote cost savings for pragmatic trials 322 hours of coordinator time on excluding ineligible participants UNC one of 18 sites Will need to investigate EHR performance characteristics at other study sites

Conclusions Reasons? Current problem list/medications not updated regularly by providers/clinical staff Time problem! Heterogeneity in asthma care among providers & patient education More complexity to inclusion criteria than other asthma trials Distinction between daily OCS v. exacerbations Change in inclusion criteria

Conclusions Lessons learned Prior to study start, identify parameters for the best computable phenotype Proper balance of sensitivity & specificity Allocate budgeted time EHR data analysts to refine computable phenotype Still need research coordinators to review charts Goal Better estimate of cost/patient enrolled Increased willingness to participate in pragmatic trials Improved patient outcomes

Acknowledgements & Questions?